Health
JAK1 Inhibitor Market Poised for Double-Digit Growth
The global JAK1 inhibitor drug market is projected to reach $3.6 billion by 2033, driven by increasing autoimmune disease prevalence and drug development.
about 4 hours ago
Manassas Chiropractor Adopts Low-Force Adjusting Methods
Manassas chiropractor Dr. Gyzel Tabrizi uses low-force instrument adjusting techniques, offering a gentle yet precise alternative for spinal and joint care.
about 22 hours ago
TNBC Clinical Trial Report Reveals Active Pipeline
DelveInsight's new report reveals over 350 active global clinical trials for Triple-Negative Breast Cancer, with immunotherapies and ADCs leading new treatments. North America holds the most studies.
8 days ago
Sensei Biotherapeutics Expands Team with Stock Grants
Sensei Biotherapeutics issued inducement stock options to three new employees under Nasdaq rules to attract key talent for its immunooncology pipeline.
9 days ago
Primary Care Physician Market Nears $1.9 Trillion by 2035
The global primary care physician market is projected to reach US$1.86 trillion by 2035, driven by an aging population and technological advancements. North America leads, while Asia Pacific anticipates the fastest growth.
11 days ago
Entrada Therapeutics Issues Inducement Grants to New Hires
Entrada Therapeutics announced inducement stock options for 32,500 shares to new employees, adhering to Nasdaq Listing Rule 5635(c)(4).
12 days ago
Revelation Biosciences Bolsters Kidney Injury Board
Revelation Biosciences expanded its Acute Kidney Injury Advisory Board with two new experts to guide the clinical development of its lead asset, REV-002.
13 days ago
Genentech to Unveil Obesity Data at ADA 2026
Genentech will present new data on its obesity portfolio, including GDC-9413 and GDC-7817, at the 2026 ADA Scientific Sessions. A new discovery program is also planned.
13 days ago
Capsule Market Projected to Hit $9.7 Billion by 2035
The global capsule market is projected to reach USD 9.7 billion by 2035, driven by rising demand for nutraceuticals and pharmaceutical R&D.
15 days ago
Cosmos Health Eyes $200M Revenue by 2029
Cosmos Health forecasts $200 million in revenue and $44 million Adjusted EBITDA by 2029, driven by a strategic shift to high-margin healthcare products.
17 days ago
Context Therapeutics CEO to Detail Pipeline at Jefferies Event
Context Therapeutics Inc. CEO Martin Lehr will present at the Jefferies Global Healthcare Conference on June 5, 2026, discussing the company's oncology pipeline, including ONC-392 and CTX-177.
18 days ago
Medicaid Oversight Shifts Spark Private Equity Scrutiny
States are scrutinizing private equity-backed Medicaid contractors following audits revealing performance and financial concerns. This intensifies debate over profit motives in public health services.
20 days ago
Global Nasal Spray Market Set for Strong Growth
The global multi-dose nasal spray market is forecast for substantial growth through 2033, driven by rising chronic respiratory conditions and technological advancements.
21 days ago
Preadium Platform Propels European EHR Market into Research Era
Preadium's platform is enabling Europe's EHR market to become "research-ready," connecting clinical trials with real-world patient data across 11 countries.
23 days ago
Immuneering's Atebimetinib Extends Pancreatic Cancer Survival
Immuneering reports 17.3 months median overall survival for atebimetinib in first-line metastatic pancreatic cancer, a promising step for patients.
23 days ago
Global Therapeutic Equipment Repair Market to Hit $32.1 Billion
The global therapeutic equipment repair and maintenance services market is set to reach USD 32.1 billion by 2032, driven by rising demand for advanced medical devices.
28 days ago
Pharma Desiccants Market Set for Robust Growth
Global pharmaceutical desiccants market is set to reach USD 2.3 billion by 2030, driven by demand for moisture-sensitive drugs.
about 1 month ago
Dermata Therapeutics Outlines Q1 2026 Financials and Clinical Growth
Dermata Therapeutics reported Q1 2026 financials, detailing a $7.8M net loss and progress in its DM1721 acne and rosacea clinical trials.
about 1 month ago